SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-19-003448
Filing Date
2019-04-29
Accepted
2019-04-29 09:16:35
Documents
57
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q qure-20190331x10q.htm 10-Q 1743925
2 EX-31.1 qure-20190331ex311c6b45c.htm EX-31.1 18176
3 EX-31.2 qure-20190331ex312cc4176.htm EX-31.2 18078
4 EX-32.1 qure-20190331ex32162131e.htm EX-32.1 11139
  Complete submission text file 0001558370-19-003448.txt   6547947

Data Files

Seq Description Document Type Size
5 EX-101.INS qure-20190331.xml EX-101.INS 1337556
6 EX-101.SCH qure-20190331.xsd EX-101.SCH 48292
7 EX-101.CAL qure-20190331_cal.xml EX-101.CAL 49698
8 EX-101.DEF qure-20190331_def.xml EX-101.DEF 233385
9 EX-101.LAB qure-20190331_lab.xml EX-101.LAB 468093
10 EX-101.PRE qure-20190331_pre.xml EX-101.PRE 366277
Mailing Address PAASHEUVELWEG 25A AMSTERDAM P7 1105 BP
Business Address PAASHEUVELWEG 25A AMSTERDAM P7 1105 BP 1-339-970-7000
uniQure N.V. (Filer) CIK: 0001590560 (see all company filings)

IRS No.: 000000000
Type: 10-Q | Act: 34 | File No.: 001-36294 | Film No.: 19773981
SIC: 2834 Pharmaceutical Preparations